Stock Analysis on Net
Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Analysis of Goodwill and Intangible Assets

Microsoft Excel

Goodwill and Intangible Asset Disclosure

Allergan Inc., balance sheet: goodwill and intangible assets

US$ in thousands

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Developed technology 648,500 647,700 1,202,800 1,111,000 1,129,600
Customer relationships 54,200 54,700 54,500 42,300 42,300
Licensing 190,500 185,800 185,900 185,800 185,600
Trademarks 89,100 89,600 87,900 26,700 27,400
Technology, related assets 335,300 327,500 182,000 181,300 189,600
Other 29,000 30,700 43,900 38,500 17,000
Amortizable intangible assets, gross amount 1,346,600 1,336,000 1,757,000 1,585,600 1,591,500
Accumulated amortization (739,200) (639,800) (807,200) (716,400) (599,800)
Amortizable intangible assets, net 607,400 696,200 949,800 869,200 991,700
In-process research and development 1,179,100 953,800 279,300 296,000 4,300
Unamortizable intangible assets 1,179,100 953,800 279,300 296,000 4,300
Intangibles 1,786,500 1,650,000 1,229,100 1,165,200 996,000
Goodwill 2,392,900 2,339,400 2,239,500 2,088,400 2,038,500
Intangibles and goodwill 4,179,400 3,989,400 3,468,600 3,253,600 3,034,500

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).


The total value of intangibles and goodwill exhibits a consistent upward trajectory over the five-year period, increasing from US$ 3,034,500 thousand in 2010 to US$ 4,179,400 thousand by 2014. This growth is characterized by a strategic shift in the composition of intangible assets, moving from amortizable developed technologies toward unamortizable in-process research and development.

Amortizable Intangible Assets
The gross amount of amortizable intangible assets peaked in 2012 at US$ 1,757,000 thousand before declining and stabilizing at US$ 1,346,600 thousand by 2014. A notable reduction in developed technology is observed between 2012 and 2013, where values dropped from US$ 1,202,800 thousand to US$ 647,700 thousand. Consequently, the net book value of these assets decreased steadily from US$ 991,700 thousand in 2010 to US$ 607,400 thousand in 2014, influenced by the accumulation of amortization over time.
Unamortizable Intangible Assets and IPR&D
A substantial increase is evident in in-process research and development (IPR&D), which rose from US$ 4,300 thousand in 2010 to US$ 1,179,100 thousand in 2014. This category represents the most aggressive growth area within the intangible portfolio, with a significant surge occurring between 2012 and 2013. The alignment between IPR&D and total unamortizable intangible assets suggests that these assets comprise the entirety of the unamortizable portfolio.
Goodwill and Aggregate Trends
Goodwill demonstrates a steady, incremental increase, rising from US$ 2,038,500 thousand in 2010 to US$ 2,392,900 thousand in 2014. The consistent growth in goodwill, coupled with the rapid expansion of IPR&D, indicates a sustained strategy of business acquisitions. Total intangibles grew from US$ 996,000 thousand to US$ 1,786,500 thousand over the period, indicating that the acquisition of new research and development pipelines outweighed the amortization of existing technology assets.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjustments to Financial Statements: Removal of Goodwill

Allergan Inc., Financial Data: Reported vs. Adjusted

Allergan Inc., adjustments to financial statements

US$ in thousands

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Adjustment to Total Assets
Total assets (as reported) 12,415,700 10,574,300 9,179,300 8,508,600 8,308,100
Less: Goodwill 2,392,900 2,339,400 2,239,500 2,088,400 2,038,500
Total assets (adjusted) 10,022,800 8,234,900 6,939,800 6,420,200 6,269,600
Adjustment to Total Allergan, Inc. Stockholders’ Equity
Total Allergan, Inc. stockholders’ equity (as reported) 7,753,000 6,463,200 5,837,100 5,309,600 4,757,700
Less: Goodwill 2,392,900 2,339,400 2,239,500 2,088,400 2,038,500
Total Allergan, Inc. stockholders’ equity (adjusted) 5,360,100 4,123,800 3,597,600 3,221,200 2,719,200

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).


Between 2010 and 2014, a consistent upward trend is observed in both reported and adjusted total assets, as well as in reported and adjusted stockholders' equity. While reported figures grew steadily, the adjusted figures—which exclude goodwill and intangible assets—demonstrated a more accelerated rate of growth over the five-year period.

Impact of Intangible Asset Removal
The gap between reported total assets and adjusted total assets indicates a substantial and growing presence of goodwill and intangible assets. This difference expanded from 2,038.5 million USD in 2010 to 2,392.9 million USD in 2014. The fact that the reduction in total assets exactly mirrors the reduction in stockholders' equity confirms that these intangible assets are primary components of the company's equity base.
Asset Growth Analysis
Reported total assets increased by approximately 49.5% from 2010 to 2014. In contrast, adjusted total assets grew by approximately 59.7% during the same period. This indicates that the growth in tangible assets outperformed the growth in intangible assets, suggesting an increase in the company's physical or liquid resource base relative to its acquisition-related premiums.
Equity and Solvency Trends
Adjusted stockholders' equity experienced significant growth, rising from 2,719.2 million USD in 2010 to 5,360.1 million USD in 2014, representing an increase of approximately 97.1%. This growth rate far exceeds the 63.0% increase seen in reported stockholders' equity. This trend suggests a substantial strengthening of the tangible net worth of the organization, reducing the proportion of equity tied to non-physical assets over time.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjusted Financial Ratios: Removal of Goodwill (Summary)

Allergan Inc., Financial Ratios: Reported vs. Adjusted

Allergan Inc., adjusted financial ratios

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Asset Turnover
Reported total asset turnover 0.57 0.59 0.62 0.63 0.58
Adjusted total asset turnover 0.71 0.75 0.82 0.83 0.77
Financial Leverage
Reported financial leverage 1.60 1.64 1.57 1.60 1.75
Adjusted financial leverage 1.87 2.00 1.93 1.99 2.31
Return on Equity (ROE)
Reported ROE 19.66% 15.24% 18.82% 17.60% 0.01%
Adjusted ROE 28.44% 23.89% 30.54% 29.01% 0.02%
Return on Assets (ROA)
Reported ROA 12.28% 9.32% 11.97% 10.98% 0.01%
Adjusted ROA 15.21% 11.96% 15.83% 14.56% 0.01%

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).


The exclusion of goodwill and intangible assets from financial calculations reveals a consistent disparity between reported and adjusted performance metrics from 2010 to 2014. The adjustment generally results in higher efficiency and profitability ratios, while simultaneously increasing the measured financial leverage, indicating that a significant portion of the asset base consists of non-physical, acquired assets.

Total Asset Turnover
A consistent positive variance is observed between reported and adjusted asset turnover ratios. Adjusted turnover peaked in 2011 at 0.83 before trending downward to 0.71 by 2014. The reported turnover followed a similar trajectory, peaking at 0.63 in 2011 and declining to 0.57 in 2014. The gap between the two metrics suggests that the removal of intangible assets significantly reduces the denominator, thereby inflating the perceived efficiency of asset utilization.
Financial Leverage
Adjusted financial leverage is systematically higher than reported leverage across the entire period. While reported leverage remained relatively stable, fluctuating between a high of 1.75 in 2010 and a low of 1.57 in 2012, adjusted leverage showed more volatility, starting at 2.31 in 2010 and ending at 1.87 in 2014. This indicates that the company's reliance on debt is more pronounced when the valuation is stripped of goodwill and intangible assets.
Return on Equity (ROE)
A substantial increase in ROE is evident when intangible assets are removed. Following a negligible start in 2010, adjusted ROE jumped to 29.01% in 2011, peaking at 30.54% in 2012. Although there was a dip to 23.89% in 2013, it recovered to 28.44% by 2014. This adjusted figure consistently outperforms the reported ROE, which reached 19.66% in 2014, demonstrating that the company generates significantly higher returns on its tangible equity base.
Return on Assets (ROA)
The trend for ROA mirrors that of ROE, with adjusted figures consistently exceeding reported values. After the 2010 baseline, adjusted ROA peaked at 15.83% in 2012 before ending the period at 15.21% in 2014. The reported ROA followed a similar pattern but remained lower, ending at 12.28% in 2014. The removal of goodwill and intangibles effectively amplifies the perceived profitability of the company's operating asset base.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
As Reported
Selected Financial Data (US$ in thousands)
Product net sales 7,126,100 6,197,500 5,708,800 5,347,100 4,819,600
Total assets 12,415,700 10,574,300 9,179,300 8,508,600 8,308,100
Activity Ratio
Total asset turnover1 0.57 0.59 0.62 0.63 0.58
Adjusted for Goodwill
Selected Financial Data (US$ in thousands)
Product net sales 7,126,100 6,197,500 5,708,800 5,347,100 4,819,600
Adjusted total assets 10,022,800 8,234,900 6,939,800 6,420,200 6,269,600
Activity Ratio
Adjusted total asset turnover2 0.71 0.75 0.82 0.83 0.77

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

2014 Calculations

1 Total asset turnover = Product net sales ÷ Total assets
= 7,126,100 ÷ 12,415,700 = 0.57

2 Adjusted total asset turnover = Product net sales ÷ Adjusted total assets
= 7,126,100 ÷ 10,022,800 = 0.71


A consistent increase in both reported and adjusted total assets is observed between 2010 and 2014. Reported total assets grew from 8,308,100 thousand US$ to 12,415,700 thousand US$, while adjusted total assets rose from 6,269,600 thousand US$ to 10,022,800 thousand US$. The widening gap between these two figures indicates a substantial and growing presence of goodwill and intangible assets on the balance sheet over the analyzed period.

Reported Total Asset Turnover
The reported turnover ratio exhibited a slight peak in 2011 at 0.63, followed by a steady decline to 0.57 by 2014. This downward trend suggests that the growth in the total asset base outpaced the growth in revenue, leading to a reduction in overall asset utilization efficiency.
Adjusted Total Asset Turnover
The adjusted turnover ratio, which excludes goodwill and intangible assets, followed a similar trajectory, peaking in 2011 at 0.83 and declining to 0.71 by 2014. Despite the decline, the adjusted ratio remained significantly higher than the reported ratio in every period, indicating that the underlying operational assets are utilized more efficiently than the total asset base suggests.
Comparative Efficiency Analysis
The positive variance between the adjusted and reported turnover ratios highlights the dilutive effect of intangible assets on the company's efficiency metrics. The fact that the adjusted turnover remains consistently higher demonstrates that the company generates a higher volume of revenue relative to its tangible or adjusted asset base. However, the simultaneous decline in both ratios from 2011 to 2014 indicates a broad trend of diminishing marginal returns on asset investment during this timeframe.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjusted Financial Leverage

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
As Reported
Selected Financial Data (US$ in thousands)
Total assets 12,415,700 10,574,300 9,179,300 8,508,600 8,308,100
Total Allergan, Inc. stockholders’ equity 7,753,000 6,463,200 5,837,100 5,309,600 4,757,700
Solvency Ratio
Financial leverage1 1.60 1.64 1.57 1.60 1.75
Adjusted for Goodwill
Selected Financial Data (US$ in thousands)
Adjusted total assets 10,022,800 8,234,900 6,939,800 6,420,200 6,269,600
Adjusted total Allergan, Inc. stockholders’ equity 5,360,100 4,123,800 3,597,600 3,221,200 2,719,200
Solvency Ratio
Adjusted financial leverage2 1.87 2.00 1.93 1.99 2.31

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

2014 Calculations

1 Financial leverage = Total assets ÷ Total Allergan, Inc. stockholders’ equity
= 12,415,700 ÷ 7,753,000 = 1.60

2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted total Allergan, Inc. stockholders’ equity
= 10,022,800 ÷ 5,360,100 = 1.87


A consistent upward trend is observed in both reported and adjusted total assets and stockholders' equity from 2010 through 2014. While reported total assets grew from 8.3 billion to 12.4 billion US dollars, adjusted total assets increased from 6.3 billion to 10.0 billion US dollars over the same period. This divergence indicates a significant presence of goodwill and intangible assets within the corporate balance sheet.

Equity Composition and Adjustments
A substantial gap exists between reported and adjusted stockholders' equity. In 2010, the adjusted equity of 2.7 billion US dollars represented approximately 57% of the reported 4.8 billion US dollars. By 2014, adjusted equity grew to 5.4 billion US dollars, representing approximately 70% of the reported 7.8 billion US dollars. This suggests that while intangible assets remain a significant component of equity, their relative weight decreased over the five-year duration.
Comparative Financial Leverage
Adjusted financial leverage is consistently higher than reported financial leverage throughout the period. Reported leverage remained relatively stable, fluctuating between 1.57 and 1.75. Conversely, adjusted financial leverage started at a significantly higher peak of 2.31 in 2010. This indicates that the exclusion of intangible assets reveals a higher degree of financial risk and reliance on debt relative to tangible equity than the reported figures suggest.
Leverage Trajectory
A general downward trend is observed in adjusted financial leverage, which declined from 2.31 in 2010 to 1.87 in 2014. Although a slight increase occurred between 2012 and 2013, the overall trajectory suggests an improvement in the company's tangible solvency position. The narrowing gap between reported and adjusted leverage ratios over time aligns with the increase in the proportion of adjusted equity relative to reported equity.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
As Reported
Selected Financial Data (US$ in thousands)
Net earnings attributable to Allergan, Inc. 1,524,200 985,100 1,098,800 934,500 600
Total Allergan, Inc. stockholders’ equity 7,753,000 6,463,200 5,837,100 5,309,600 4,757,700
Profitability Ratio
ROE1 19.66% 15.24% 18.82% 17.60% 0.01%
Adjusted for Goodwill
Selected Financial Data (US$ in thousands)
Net earnings attributable to Allergan, Inc. 1,524,200 985,100 1,098,800 934,500 600
Adjusted total Allergan, Inc. stockholders’ equity 5,360,100 4,123,800 3,597,600 3,221,200 2,719,200
Profitability Ratio
Adjusted ROE2 28.44% 23.89% 30.54% 29.01% 0.02%

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

2014 Calculations

1 ROE = 100 × Net earnings attributable to Allergan, Inc. ÷ Total Allergan, Inc. stockholders’ equity
= 100 × 1,524,200 ÷ 7,753,000 = 19.66%

2 Adjusted ROE = 100 × Net earnings attributable to Allergan, Inc. ÷ Adjusted total Allergan, Inc. stockholders’ equity
= 100 × 1,524,200 ÷ 5,360,100 = 28.44%


An analysis of stockholders' equity and return on equity (ROE) from 2010 to 2014 reveals a consistent growth trend in the capital base alongside a significant disparity between reported and adjusted performance metrics.

Stockholders' Equity Trends
Reported total stockholders' equity increased steadily from US$ 4,757,700 thousand in 2010 to US$ 7,753,000 thousand by 2014. During the same period, adjusted total stockholders' equity grew from US$ 2,719,200 thousand to US$ 5,360,100 thousand. The adjusted figures remain consistently and substantially lower than the reported figures, indicating the presence of significant goodwill and intangible assets within the equity structure.
Return on Equity (ROE) Analysis
Reported ROE exhibited a sharp ascent from 0.01% in 2010 to 19.66% in 2014. Adjusted ROE followed a similar upward trajectory from 0.02% in 2010, peaking at 30.54% in 2012 and ending at 28.44% in 2014. Throughout the observation period, adjusted ROE consistently exceeded reported ROE, with the most pronounced gap occurring between 2011 and 2014.
Impact of Intangible Asset Adjustments
The variance between the two ROE metrics demonstrates that the inclusion of goodwill and intangible assets in the reported equity base suppresses the return percentage. The higher adjusted ROE indicates that the return on tangible equity is significantly stronger, suggesting that operational profitability is more efficient when the dilutive effect of non-physical assets is removed from the calculation.

The trajectory of the data indicates that while the company expanded its total equity base, the underlying returns on adjusted equity remained high, maintaining a premium of approximately 9 to 12 percentage points over reported returns from 2011 onward.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
As Reported
Selected Financial Data (US$ in thousands)
Net earnings attributable to Allergan, Inc. 1,524,200 985,100 1,098,800 934,500 600
Total assets 12,415,700 10,574,300 9,179,300 8,508,600 8,308,100
Profitability Ratio
ROA1 12.28% 9.32% 11.97% 10.98% 0.01%
Adjusted for Goodwill
Selected Financial Data (US$ in thousands)
Net earnings attributable to Allergan, Inc. 1,524,200 985,100 1,098,800 934,500 600
Adjusted total assets 10,022,800 8,234,900 6,939,800 6,420,200 6,269,600
Profitability Ratio
Adjusted ROA2 15.21% 11.96% 15.83% 14.56% 0.01%

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

2014 Calculations

1 ROA = 100 × Net earnings attributable to Allergan, Inc. ÷ Total assets
= 100 × 1,524,200 ÷ 12,415,700 = 12.28%

2 Adjusted ROA = 100 × Net earnings attributable to Allergan, Inc. ÷ Adjusted total assets
= 100 × 1,524,200 ÷ 10,022,800 = 15.21%


An analysis of the financial position between December 31, 2010, and December 31, 2014, reveals a consistent upward trajectory in total assets. Reported total assets increased from 8,308,100 thousand US$ to 12,415,700 thousand US$, while adjusted total assets grew from 6,269,600 thousand US$ to 10,022,800 thousand US$. The persistent gap between these two figures indicates a significant presence of goodwill and intangible assets on the balance sheet.

Asset Base Evolution
A steady expansion of the asset base is observed over the five-year period. Reported assets grew by approximately 49.5%, while adjusted assets grew by 59.8%. This suggests that the growth in tangible or adjusted assets slightly outpaced the growth of the overall asset base, including intangibles.
Reported Return on Assets (ROA)
Following a negligible return of 0.01% in 2010, the reported ROA experienced significant volatility. It climbed to 10.98% in 2011 and peaked at 11.97% in 2012, before declining to 9.32% in 2013 and recovering to 12.28% in 2014.
Adjusted Return on Assets (ROA)
The adjusted ROA follows a similar trend pattern to the reported ROA but maintains consistently higher values from 2011 onward. After the initial 0.01% in 2010, the adjusted ROA rose to 14.56% in 2011, reached a high of 15.83% in 2012, dipped to 11.96% in 2013, and concluded the period at 15.21% in 2014.

The divergence between reported and adjusted ROA demonstrates that the inclusion of goodwill and intangible assets suppresses the perceived efficiency of asset utilization. By removing these non-physical assets from the denominator, a higher rate of return is revealed, suggesting that the core operational assets are generating profits more efficiently than the total balance sheet figures suggest. The synchronized dip in both ROA metrics during 2013 indicates a systemic decline in profitability or a temporary spike in asset acquisition that did not immediately yield proportional returns.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?